Amedisys, Inc.

Informe acción NasdaqGS:AMED

Capitalización de mercado: US$2.9b

Amedisys Dirección

Dirección controles de criterios 1/4

El CEO de Amedisys es Richard Ashworth , nombrado en Apr 2023, tiene una permanencia de 1.58 años. compensación anual total es $16.97M, compuesta por 4.1% salario y 95.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.088% de las acciones de la empresa, por valor de $2.59M. La antigüedad media del equipo directivo y de la junta directiva es de 1.6 años y 5 años, respectivamente.

Información clave

Richard Ashworth

Chief Executive Officer (CEO)

US$17.0m

Compensación total

Porcentaje del salario del CEO4.1%
Permanencia del CEO1.6yrs
Participación del CEO0.09%
Permanencia media de la dirección1.6yrs
Promedio de permanencia en la Junta Directiva5yrs

Actualizaciones recientes de la dirección

Recent updates

Final Push For Amedisys As UnitedHealth Awaits Regulatory Clearance

Nov 05

Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?

Apr 10
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?

Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?

Feb 25
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?

Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around

Feb 10
Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around

At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Jan 03
At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Dec 16
A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal

Nov 12
Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal

Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?

Sep 19
Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?

An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued

Sep 04
An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued

Amedisys: ROIC, Tangible Book Value Each Softening

Aug 24

Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement

Aug 04
Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement

Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates

Jul 27

We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt

Jul 20
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt

At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Jun 04
At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled

May 05
Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled

Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?

Apr 20
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?

Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?

Apr 06
Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?

Is Amedisys (NASDAQ:AMED) A Risky Investment?

Feb 20
Is Amedisys (NASDAQ:AMED) A Risky Investment?

Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue

Jan 19
Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue

Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

Dec 03
Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely

Nov 18
These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely

Amedisys (NASDAQ:AMED) Could Easily Take On More Debt

Aug 18
Amedisys (NASDAQ:AMED) Could Easily Take On More Debt

Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Jul 23
Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity

Jul 18

Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive

Jun 28
Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive

It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package

Jun 02
It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package

Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

May 24
Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Richard Ashworth en comparación con los beneficios de Amedisys?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

US$83m

Jun 30 2024n/an/a

US$92m

Mar 31 2024n/an/a

-US$21m

Dec 31 2023US$17mUS$692k

-US$10m

Compensación vs. Mercado: La compensación total de Richard($USD16.97M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD6.60M).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Richard con los resultados de la empresa.


CEO

Richard Ashworth (49 yo)

1.6yrs

Permanencia

US$16,974,025

Compensación

Mr. Richard M. Ashworth served as Director at Tivity Health, Inc. since June 1, 2020 until April 2023 and had been its President since June 1, 2020 and served as its Chief Executive Officer since June 1, 2...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Richard Ashworth
President1.6yrsUS$16.97m0.088%
$ 2.6m
Scott Ginn
Executive VP7.1yrsUS$4.45m0.077%
$ 2.3m
Denise Bohnert
Chief Compliance Officer5.2yrsUS$1.28msin datos
Nick Muscato
Chief Strategy Officerno dataUS$1.37m0.0065%
$ 191.6k
Allyson Guidroz
Chief Accounting Officer & Principal Accounting Officer1.3yrssin datos0.0097%
$ 285.0k
Pete Hartley
CTO & Senior VP of Business Operations Systemsno datasin datossin datos
Keith Blanchard
Acting Chief Information Officerless than a yearsin datossin datos
Jennifer Griffin
Senior VP2.1yrssin datos0.054%
$ 1.6m
Kendra Kimmons
VP of Marketing & Communications & Media Relationsno datasin datossin datos
Caitlin Franklin
Acting Chief People Officerless than a yearsin datossin datos
Francis Mayer
Senior Vice President of Developmentno datasin datossin datos

1.6yrs

Permanencia media

47.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de AMED no se considera experimentado ( 1.6 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Richard Ashworth
President1.6yrsUS$16.97m0.088%
$ 2.6m
Paul Kusserow
Chairman9.9yrsUS$4.00m1.33%
$ 39.3m
Bruce Perkins
Independent Director9.6yrsUS$267.62k0.063%
$ 1.9m
Vickie Capps
Independent Director5yrsUS$277.62k0.020%
$ 580.4k
Molly Coye
Independent Director5yrsUS$267.62k0.017%
$ 490.5k
Julie Klapstein
Lead Independent DIrector8.6yrsUS$282.62k0.039%
$ 1.1m
Jeffrey Rideout
Independent Director8.6yrsUS$267.62k0.018%
$ 537.1k
Teresa Kline
Independent Director5yrsUS$272.62k0.020%
$ 580.4k
Ivanetta Samuels
Independent Director3.9yrsUS$252.62k0.013%
$ 380.8k

5.0yrs

Permanencia media

63yo

Promedio de edad

Junta con experiencia: La junta directiva de AMED se considera experimentada (5 años de antigüedad promedio).